The rousing biographical drama centred on one of the most renowned figures in science will be leaving Netflix on August 16.

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

The regulatory clearances that have been conducted in both the U.S. and China, demonstrating the momentum behind SNUG01's global development. Through strategic collaborations and scientific rigor, ...